Addex Therapeutics Ltd. (ADXN) Accumulated Expenses (2022 - 2024)

Addex Therapeutics' Accumulated Expenses history spans 3 years, with the latest figure at $592276.3 for Q4 2024.

  • For Q4 2024, Accumulated Expenses fell 57.47% year-over-year to $592276.3; the TTM value through Dec 2024 reached $592276.3, down 57.47%, while the annual FY2024 figure was $589775.3, 57.12% down from the prior year.
  • Accumulated Expenses for Q4 2024 was $592276.3 at Addex Therapeutics, down from $1.4 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.7 million in Q4 2022 and bottomed at $592276.3 in Q4 2024.
  • The 3-year median for Accumulated Expenses is $1.4 million (2023), against an average of $1.2 million.
  • The largest annual shift saw Accumulated Expenses fell 16.07% in 2023 before it tumbled 57.47% in 2024.
  • A 3-year view of Accumulated Expenses shows it stood at $1.7 million in 2022, then decreased by 16.07% to $1.4 million in 2023, then crashed by 57.47% to $592276.3 in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Accumulated Expenses are $592276.3 (Q4 2024), $1.4 million (Q4 2023), and $1.7 million (Q4 2022).